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BOLD
  (blood
  oxygen
  level
  dependent)
  fMRI
  (functional
  magnetic
  resonance
  imaging)
  is
commonly
  used
  to
  study
  differences
  in
  neuronal
  activity
  between
  human
  populations.
  As
the
  BOLD
  response
  is
  an
  indirect
  measure
  of
  neuronal
  activity,
  meaningful
  interpretation
of
  differences
  in
  BOLD
  responses
  between
  groups
  relies
  upon
  a
  stable
  relationship
  exist-
ing
  between
  neuronal
  activity
  and
  the
  BOLD
  response
  across
  these
  groups.
  However,
  this
relationship
  can
  be
  altered
  by
  changes
  in
  neurovascular
  coupling
  or
  energy
  consumption,
which
 would
 lead
 to
 problems
 in
 identifying
 differences
 in
 neuronal
 activity.
 In
 this
 review,
we
  focus
  on
  fMRI
  studies
  of
  people
  with
  autism,
  and
  comparisons
  that
  are
  made
  of
  their
BOLD
  responses
  with
  those
  of
  control
  groups.
  We
  examine
  neurophysiological
  differences
in
  autism
  that
  may
  alter
  neurovascular
  coupling
  or
  energy
  use,
  discuss
  recent
  studies
  that
have
  used
  fMRI
  to
  identify
  differences
  between
  participants
  with
  autism
  and
  control
  par-
ticipants,
  and
  explore
  experimental
  approaches
  that
  could
  help
  attribute
  between-group
differences
  in
  BOLD
  signals
  to
  either
  neuronal
  or
  neurovascular
  factors.
© 2013 Elsevier Ltd. 
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1.
  Introduction
Many
  important
  questions
  in
  neuroscience
  and
  neu-
rology
  concern
  differences
  in
  brain
  activity
  between
  two
or
  more
  groups
  of
  people.
  Because
  fMRI
  is
  a
  powerful
  and
non-invasive
  tool
  to
  examine
  brain
  function
  in
  humans,
it
  is
  often
  employed
  to
  read
  out
  neuronal
  activity
  in
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such
  studies.
  However,
  for
  fMRI-based
  measures
  of
  brain
activity
  to
  be
  reliably
  compared
  between
  populations,
  it
must
  be
  assumed
  that
  the
  relationship
  between
  neuronal
activity
  and
  the
  BOLD
  signal
  is
  the
  same
  in
  the
  different
groups.
  This
  relationship
  depends
  on
  the
  mechanism
  by
which
  active
  neurons
  alter
  local
  blood
  ﬂow
  (neurovascular
coupling)
  and
  on
  the
  oxygen
  use
  evoked
  by
  neuronal
activity
  (Attwell
  and
  Iadecola,
  2002;
  Harris
  et
  al.,
  2011).
Several
  neurophysiological
  changes
  have
  been
  identi-
ﬁed
  in
  autism
  (as
  discussed
  below).
  These
  changes
  may
alter
  the
  signalling
  from
  neurons
  to
  the
  vasculature
  and,
in
  consequence,
  the
  relationship
  between
  neuronal
  activ-
ity
  and
  the
  BOLD
  signal.
  Typically,
  studies
  using
  fMRI
to
  compare
  control
  participants
  and
  participants
  with
autism
  attribute
  observed
  differences
  in
  the
  BOLD
  sig-
nal
  to
  altered
  neuronal
  activity,
  without
  considering
  the
possibility
  that
  neurovascular
  coupling
  or
  oxygen
  con-
sumption
  is
  also
  altered
  (Goldberg
  et
  al.,
  2011;
  Pfeifer
et
 al.,
 2012;
 Watanabe
 et
 al.,
 2012).
 More
 recently,
 however,
researchers
  have
  begun
  to
  acknowledge
  that
  neurovascu-
lar
 coupling
 or
 oxygen
 use
 changes
 must
 be
 experimentally
ruled
  out
  before
  BOLD
  differences
  can
  be
  used
  as
  evi-
dence
  for
  differences
  of
  neuronal
  function
  between
  control
and
  autistic
  groups
  (Dinstein
  et
  al.,
  2012;
  Feczko
  et
  al.,
2012).
In
  this
  article,
  we
  start
  by
  brieﬂy
  reviewing
  the
  phys-
iological
  basis
  of
  the
  BOLD
  signal
  and
  the
  neurovascular
coupling
  mechanisms
  that
  mediate
  it.
  We
  then
  look
  in
detail
  at
  the
  neurophysiological
  changes
  that
  are
  known
to
  occur
  in
  autism
  and
  how
  these
  changes
  might
  inﬂuence
neurovascular
 coupling
 and
 oxygen
 use,
 and
 thus
 the
 BOLD
response.
  We
  then
  examine
  the
  implications
  that
  altered
neurovascular
  coupling
  or
  oxygen
  use
  would
  have
  for
  fMRI
studies.
  By
  focusing
  on
  several
  representative
  studies
  cho-
sen
  from
  the
  literature,
  we
  highlight
  the
  interpretational
problems
  that
  can
  occur
  when
  this
  issue
  is
  ignored.
  Finally,
we
  explore
  ways
  in
  which
  the
  scientiﬁc
  community
  study-
ing
  autism
  can
  address
  the
  challenge
  of
  separating
  out
neurovascular
 coupling
 and
 neuronal
 activity
 effects
 on
 the
BOLD
  signal
  experimentally,
  as
  some
  groups
  are
  already
beginning
  to
  do.
2.
  Neurovascular
  coupling
  and
  the
  BOLD
  signal
fMRI
  is
  regularly
  used
  to
  study
  neuronal
  activity
  in
humans
  because
  of
  its
  non-invasive
  nature,
  which
  allows
it
  to
  be
  used
  to
  study
  a
  broad
  range
  of
  participants,
  includ-
ing
  patients
  suffering
  from
  pathologies
  such
  as
  autism.
  It
is
  important
  to
  note,
  however,
  that
  the
  signal
  produced
–
  the
  BOLD
  signal
  –
  is
  not
  a
  direct
  measure
  of
  neu-
ronal
  activity,
  but
  instead
  reﬂects
  the
  operation
  of
  several
different
  brain
  processes
  associated
  with
  neuronal
  activ-
ity,
  including
  synaptic
  transmitter
  release,
  the
  resulting
release
  of
  signalling
  molecules
  that
  mediate
  neurovas-
cular
  coupling
  and
  thus
  increase
  local
  blood
  ﬂow,
  and
(making
  the
  BOLD
  signal
  smaller)
  oxygen
  consumption
(Logothetis
  et
  al.,
  2001;
  Magistretti
  et
  al.,
  1999;
  Attwell
et
  al.,
  2010).
The
  BOLD
  signal
  reports
  changes
  in
  the
  amount
  of
deoxyhaemoglobin
  in
  the
  blood.
  Deoxyhaemoglobin
  is
paramagnetic,
  and
  it
  decreases
  MRI
  signals
  by
  making
the
  local
  magnetic
  ﬁeld
  less
  homogenous.
  During
  neu-
ronal
  activity,
  the
  level
  of
  deoxyhaemoglobin
  initially
increases
  as
  oxygen
  use
  increases,
  and
  then
  decreases
  as
a
  blood
  ﬂow
  increase
  occurs
  which
  over-compensates
  for
the
  amount
  of
  oxygen
  used.
  This
  decrease
  in
  the
  level
  of
deoxyhaemoglobin
  results
  in
  a
  more
  homogeneous
  mag-
netic
  ﬁeld
  and
  thus
  increases
  the
  magnetic
  resonance
signal.
  The
  size
  of
  the
  BOLD
  signal
  is
  larger
  when
  there
is
  a
  large
  blood
  ﬂow
  increase,
  but
  is
  decreased
  by
  the
use
  of
  oxygen
  by
  neurons
  (for
  a
  detailed
  description,
  see
Logothetis
  and
  Wandell,
  2004).
  In
  what
  follows
  we
  focus
simply
  on
  the
  amplitude
  of
  the
  BOLD
  signal,
  because
although
  BOLD
  signals
  are
  often
  analysed
  in
  terms
  of
their
  stimulus-evoked
  amplitude
  relative
  to
  the
  ongoing
noise,
  a
  procedure
  that
  requires
  detailed
  statistical
  analy-
sis
  (Friston,
  1995;
  Friston
  et
  al.,
  2007),
  even
  considering
just
  the
  amplitude
  of
  the
  signal
  reveals
  signiﬁcant
  con-
cerns
  about
  how
  to
  compare
  control
  and
  autistic
  groups
of
  subjects.
When
  using
  fMRI
  to
  identify
  differences
  in
  neuronal
activity
  between
  groups,
  we
  rely
  upon
  the
  assump-
tion
  that
  the
  BOLD
  signal
  represents
  the
  same
  set
  of
processes
  occurring
  in
  these
  different
  groups,
  despite
the
  neurophysiological
  differences
  found
  in
  patholo-
gies
  such
  as
  autism.
  Neurophysiological
  differences
  may
include
  neuronal
  activity
  differences,
  which
  is
  what
  most
researchers
  are
  interested
  in
  characterising.
  However,
they
  may
  also
  include
  differences
  in
  other
  processes
linked
  to
  neuronal
  activity,
  such
  as
  oxygen
  consump-
tion
  or
  neurovascular
  coupling.
  Neurovascular
  coupling
involves
  several
  pathways,
  both
  neuronal
  and
  glial,
  that
lead
  to
  the
  release
  of
  vasoactive
  mediators,
  such
  as
nitric
  oxide,
  prostaglandins
  and
  20-HETE.
  These
  alter
vessel
  diameter
  by
  promoting
  either
  smooth
  muscle
  relax-
ation,
  which
  increases
  vessel
  diameter,
  or
  smooth
  muscle
contraction,
  which
  decreases
  vessel
  diameter
  (reviewed
by
  Attwell
  et
  al.,
  2010).
  Changes
  in
  how
  the
  release
of
  any
  of
  these
  mediators
  are
  controlled
  by
  neuronal
activity
  may
  alter
  the
  relationship
  between
  neuronal
activity
  and
  the
  BOLD
  signal,
  potentially
  obscuring
  any
differences
  in
  neuronal
  activity
  between
  the
  groups
  stud-
ied.
In
  order
  to
  be
  sure
  that
  a
  BOLD
  signal
  difference
between
  groups
  reﬂects
  a
  neuronal
  activity
  difference,
  it
  is
important
  that
  we
  understand
  as
  much
  as
  possible
  about
the
  factors
  contributing
  to
  the
  BOLD
  signal.
  This
  means
considering
  not
  only
  the
  role
  of
  neuronal
  activity,
  but
  also
the
  involvement
  of
  other
  factors,
  including
  neurovascular
coupling
  and
  oxygen
  consumption,
  which
  may
  differ
  in
certain
  pathologies.
3.
  Does
  neurovascular
  coupling
  differ
  in
  autism?
As
  research
  into
  the
  pathology
  of
  autism
  progresses,
we
  are
  gaining
  insight
  into
  the
  neurophysiological
  abnor-
malities
  of
  the
  autistic
  brain
  (reviewed
  in
  Belger
  et
  al.,
2011),
 and
 developing
 therapeutic
 strategies
 to
 target
 them
(reviewed
  in
  Hampson
  et
  al.,
  2012).
  It
  is
  probable
  that
  the
relationship
  between
  neuronal
  activity
  and
  blood
  ﬂow
  is
affected
 by
 some
 of
 these
 abnormalities,
 or
 the
 medications
used
  to
  treat
  them,
  as
  follows
  (Fig.
  1).74 C.
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Fig.
  1.
  Pathways
  from
  interneurons,
  neurons
  and
  astrocytes
  that
  regulate
  blood
  ﬂow,
  leading
  to
  either
  dilation
  (black
  arrows
  to
  upper
  half
  of
  blood
  vessel)
or
  constriction
  (black
  arrows
  to
  lower
  half
  of
  blood
  vessel)
  of
  the
  nearby
  vasculature.
  Red
  arrows
  indicate
  how
  points
  in
  these
  pathways
  are
  altered
  in
autism.
  These
  changes
  may
  affect
  the
  relationship
  between
  neuronal
  activity
  and
  blood
  ﬂow
  response.
  On
  the
  left,
  excitatory
  synapses
  release
  glutamate
onto
  both
  interneurons
  and
  excitatory
  neurons.
  In
  interneurons,
  activation
  of
  glutamate
  receptors
  leads
  to
  the
  production
  of
  nitric
  oxide,
  a
  diffusible
vasodilatory
  messenger.
  It
  also
  triggers
  the
  release
  of
  GABA,
  which
  inhibits
  postsynaptic
  excitatory
  neurons,
  reducing
  downstream
  glutamate
  release.
  The
action
  of
  glutamate
  on
  astrocytic
  mGluRs
  leads
  to
  the
  production
  of
  both
  vasoactive
  dilators
  and
  constrictors
  (note,
  recent
  evidence
  suggests
  that
  mGluRs
are
  only
  present
  on
  astrocytes
  during
  infancy;
  Sun
  et
  al.,
  2013;
  see
  text).
  Serotonin
  release
  provides
  a
  basal
  constriction
  of
  blood
  vessels.
  (For
  interpretation
of
  the
  references
  to
  colour
  in
  this
  ﬁgure
  legend,
  the
  reader
  is
  referred
  to
  the
  web
  version
  of
  the
  article.)
4.
  Abnormalities
  in
  neuronal
  activity
Decreased
  inhibition
  is
  observed
  in
  the
  brains
  of
  autis-
tic
  patients:
  the
  expression
  of
  the
  enzymes
  that
  synthesise
the
  inhibitory
  neurotransmitter,
  GABA,
  and
  the
  expression
of
  the
  receptors
  on
  which
  GABA
  acts
  are
  both
  reduced
in
  the
  autistic
  brain
  (Fatemi
  et
  al.,
  2002,
  2009,
  2010).
This
  decreased
  inhibition
  is
  a
  possible
  therapeutic
  target
for
  treatment
  of
  autism,
  and
  several
  drugs
  that
  enhance
the
  action
  of
  GABA
  are
  currently
  in
  phase
  II
  clinical
  tri-
als
  (divalproex
  and
  arbaclofen;
  clinicaltrials.gov
  identiﬁer
NCT00211757
  and
  NCT00846547,
  respectively).
  The
  effect
of
 decreased
 inhibition
 on
 neuronal
 activity
 can
 be
 detected
by
  fMRI:
  because
  GABA
  decreases
  excitability,
  an
  autistic
brain
 with
 impaired
 GABA
 function
 would
 experience
 more
neuronal
  excitability
  and
  therefore
  more
  neuronal
  ﬁring
and
  more
  glutamate
  release,
  which
  triggers
  the
  release
  of
vasodilators
  and
  increases
  blood
  ﬂow
  (Attwell
  et
  al.,
  2010).
An
  increase
  in
  BOLD
  activity
  would
  thus
  be
  expected,
  and
in
 this
 case
 it
 would
 be
 related
 to
 changes
 in
 neuronal
 func-
tion.
However,
  one
  major
  issue
  with
  this
  is
  the
  potential
for
  nonlinearities
  in
  the
  relationships
  between
  inhibition,
excitation
  and
  blood
  ﬂow
  response.
  For
  instance,
  if
  GABA
activity
  decreases
  by
  half,
  neuronal
  excitability
  will
  not
necessarily
  double
  –
  simplistically,
  it
  could
  increase
  by
much
  more
  than
  a
  factor
  of
  two
  if
  the
  depolarising
  effect
  of
reduced
 GABA
 takes
 most
 neurons
 from
 below
 to
 above
 the
threshold
  for
  action
  potential
  ﬁring,
  or
  it
  could
  increase
  by
less
  than
  a
  factor
  of
  two
  if
  the
  depolarising
  effect
  is
  not
  suf-
ﬁcient
  to
  cross
  this
  threshold
  for
  most
  neurons.
  Similarly,
if
  neuronal
  excitability
  doubles,
  the
  blood
  ﬂow
  response
will
  not
  necessarily
  double
  –
  it
  could
  increase
  by
  very
  little
if
  blood
  vessels
  are
  already
  near-maximally
  dilated,
  which
may
  be
  the
  case
  much
  of
  the
  time
  in
  brains
  where
  reduced
GABA
  function
  increases
  the
  level
  of
  resting
  excitability.
A
  further
  complication
  comes
  from
  the
  recent
  suggestion
that
  GABA
  released
  from
  interneurons
  may
  act
  on
  glial
cells
  or
  directly
  on
  microvessels
  to
  increase
  blood
  ﬂow
(Kocharyn
  et
  al.,
  2008).
  A
  reduced
  action
  of
  this
  pathway
in
  autistic
  patients
  would
  lead
  to
  a
  decreased
  BOLD
  signal,
unrelated
  to
  neuronal
  excitability.C.
  Reynell,
  J.J.
  Harris
  /
  Developmental
  Cognitive
  Neuroscience
  6 (2013) 72–
  79 75
How
 the
 BOLD
 signal
 is
 affected
 overall
 by
 the
 change
 of
GABAergic
  inhibition
  in
  autism
  will
  depend,
  therefore,
  on
the
  relative
  magnitude
  of
  these
  opposing
  effects
  of
  GABA
on
  blood
  ﬂow,
  which
  may
  vary
  between
  brain
  regions.
5.
  Abnormalities
  in
  vasoactive
  mediators
Other
  neurophysiological
  changes
  observed
  in
  autism
include
  alterations
  in
  the
  signalling
  pathways
  mediating
neurovascular
 coupling
 (for
 a
 review
 of
 neurovascular
 cou-
pling
 pathways,
 see
 Attwell
 et
 al.,
 2010).
 For
 instance,
 there
is
  a
  possible
  role
  for
  nitric
  oxide
  –
  a
  vasodilator
  released
by
  neurons
  in
  response
  to
  activity
  –
  in
  the
  pathogenesis
  of
autism.
  A
  study
  using
  an
  animal
  model
  of
  autism,
  involving
prenatal
 human
 inﬂuenza
 viral
 infection,
 found
 region-
 and
time-dependent
  changes
  in
  the
  expression
  of
  nNOS,
  the
neuronal
  enzyme
  which
  produces
  nitric
  oxide.
  Expression
of
  nNOS
  was
  increased
  in
  rostral
  brain
  areas
  at
  adoles-
cence
 but
 eventually
 down-regulated
 in
 adulthood
 (Fatemi
et
  al.,
  2000).
  Support
  for
  increased
  NO
  activity
  during
development
  in
  autism
  has
  also
  been
  found
  by
  assess-
ment
  of
  NO
  production.
  Expression
  of
  adrenomedullin,
which
  stimulates
  NO
  release,
  and
  generation
  of
  nitrite,
  a
metabolic
  product
  of
  NO,
  are
  increased
  in
  children
  with
autism
  (Zoro˘ glu
  et
  al.,
  2003).
  These
  ﬁndings
  suggest
  that,
during
  development,
  more
  nitric
  oxide
  will
  be
  released
  in
response
  to
  the
  same
  amount
  of
  activity,
  which
  would
  lead
to
 an
 increased
 haemodynamic
 response
 (and
 BOLD
 signal)
in
  autistic
  versus
  control
  groups.
The
  expression
  of
  a
  speciﬁc
  subtype
  of
  metabotropic
glutamate
  receptor,
  mGluR5,
  is
  also
  increased
  in
  children
–
  but
  not
  adults
  –
  with
  autism
  (Fatemi
  et
  al.,
  2011;
  Fatemi
and
  Folsom,
  2011).
  Activation
  of
  these
  receptors
  on
  astro-
cytes
  by
  glutamate
  released
  during
  synaptic
  transmission
leads
  to
  the
  production
  and
  release
  of
  several
  vasoactive
messengers,
  which
  can
  either
  increase
  or
  decrease
  blood
ﬂow
  (Attwell
  et
  al.,
  2010).
  Interestingly,
  recent
  evidence
suggests
  that
  mGluR5
  is
  only
  present
  on
  astrocytes
  dur-
ing
  infancy;
  in
  adulthood,
  mGluR5
  expression
  stays
  high
  in
neurons
  but
  is
  diminished
  in
  astrocytes
  (Sun
  et
  al.,
  2013).
Thus,
  it
  is
  possible
  that
  the
  increased
  mGluR5
  in
  early
autism
  is
  associated
  with
  excess
  expression
  in
  astrocytes,
which
  would
  imply
  an
  abnormal
  relationship
  between
synaptic
  activity
  and
  haemodynamic
  response
  in
  children
–
  but
  not
  necessarily
  adults
  –
  with
  autism.
  Alternatively,
the
  increased
  mGluR5
  expression
  in
  children
  with
  autism
could
  have
  nothing
  to
  do
  with
  astrocytes
  –
  the
  Western
blot
  analyses
  carried
  out
  on
  post-mortem
  tissue
  did
  not
have
  cell-type
  resolution
  (Fatemi
  et
  al.,
  2011;
  Fatemi
  and
Folsom,
  2011).
  Determining
  whether
  the
  upregulation
  of
mGluR5
  in
  children
  with
  autism
  is
  associated
  with
  neu-
ronal
  or
  astrocytic
  expression
  will
  be
  key
  to
  categorising
this
 change
 as
 a
 relevant
 or
 confounding
 factor
 in
 the
 inter-
pretation
  of
  BOLD
  signal
  differences.
Finally,
  global
  serotonin
  synthesis
  is
  abnormally
  low
  in
children
  with
  autism
  but,
  in
  adolescence,
  it
  increases
  grad-
ually
  to
  1.5
  times
  the
  level
  in
  adult
  controls
  (Chugani
  et
  al.,
1999a).
 In
 children
 with
 autism,
 the
 action
 of
 the
 presynap-
tic
  transporter
  responsible
  for
  active
  serotonin
  reuptake
after
  synaptic
  signalling
  is
  also
  reduced
  (Makkonen
  et
  al.,
2008).
  The
  authors
  suggest
  that
  this
  is
  because
  fewer
serotonergic
  terminals,
  and
  therefore
  transporters
  them-
selves,
  are
  present
  in
  children
  with
  autism.
  If
  the
reduction
  in
  serotonin
  synthesis
  and
  release
  is
  matched
or
  exceeded
  by
  the
  reduction
  in
  serotonin
  reuptake,
this
  would
  be
  in
  line
  with
  the
  general
  view
  that
the
  action
  of
  serotonin
  is
  decreased
  in
  early
  autism.
On
  the
  other
  hand,
  if
  the
  number
  of
  transporters
  is
reduced
  beyond
  the
  reduction
  in
  serotonin
  release,
this
  would
  tend
  to
  increase
  the
  action
  of
  synapti-
cally
  released
  serotonin.
  Because
  serotonin
  is
  thought
  to
produce
  a
  basal
  constriction
  of
  blood
  vessels
  (Cohen
  et
  al.,
1997),
  either
  a
  decrease
  or
  an
  increase
  in
  serotonergic
activity
  could
  change
  vessel
  tone,
  and
  thus
  alter
  the
  vessel
response
  to
  the
  vasodilators
  released
  by
  a
  given
  amount
of
  neuronal
  activity
  (Blanco
  et
  al.,
  2008).
  For
  example,
  in
low
  levels
  of
  serotonin,
  a
  vessel
  may
  already
  be
  close
  to
its
  maximal
  diameter
  and
  thus
  be
  less
  able
  to
  dilate
  in
response
  to
  neuronal
  activity,
  resulting
  in
  a
  smaller
  BOLD
response.
  Conversely,
  in
  high
  levels
  of
  serotonin,
  an
  highly
constricted
  vessel
  could
  allow
  a
  larger
  dilation
  in
  response
to
  the
  same
  amount
  of
  activity,
  leading
  to
  a
  larger
  BOLD
response.
 Alternatively,
 increased
 vessel
 tone
 could
 make
 it
more
 difﬁcult
 for
 the
 vessel
 to
 dilate
 (if
 a
 larger
 vasodilatory
signal
  were
  needed
  to
  overcome
  the
  constriction),
  lead-
ing
  to
  a
  smaller
  BOLD
  response.
  More
  research
  is
  required
before
  we
  can
  predict
  exactly
  how
  altered
  basal
  tone
  will
affect
  activity-evoked
  blood
  ﬂow
  responses.
6.
  Abnormalities
  in
  energy
  use
Although
  some
  evidence
  suggests
  that
  there
  is
  no
change
  in
  metabolism
  (DeVolder
  et
  al.,
  1987;
  Herold
  et
  al.,
1988;
  Kaya
  et
  al.,
  2002),
  several
  studies
  ﬁnd
  metabolic
alterations
  in
  autism
  (Rumsey
  et
  al.,
  1985;
  Chugani
  et
  al.,
1999b;
  Weiss
  et
  al.,
  2007,
  2008,
  2009,
  2012).
  For
  instance,
Rumsey
  et
  al.
  (1985)
  used
  positron
  emission
  tomography
to
  show
  that
  glucose
  utilisation
  was
  higher
  in
  adult
  males
with
  autism
  than
  in
  controls.
  In
  an
  animal
  model
  of
  autism,
the
  Eker
  rat,
  basal
  oxygen
  consumption
  was
  found
  to
  be
  as
much
  as
  50%
  higher
  than
  that
  of
  control
  rats
  (Weiss
  et
  al.,
2007).
This
  increase
  in
  glucose
  and
  oxygen
  use
  could
  indi-
cate
  a
  greater
  need
  for
  energy
  in
  the
  autistic
  group.
  In
line
  with
  this
  is
  the
  suggestion
  that
  the
  increased
  oxy-
gen
  use
  and
  cerebral
  blood
  ﬂow
  in
  Eker
  rats
  is
  due
  to
  a
reduced
  basal
  activity
  of
  GABAA receptors
  (Weiss
  et
  al.,
2008),
  which
  would
  lead
  to
  an
  overall
  increase
  in
  neuronal
activity,
  and
  therefore
  a
  greater
  energy
  demand.
  However,
the
  increased
  oxygen
  use
  in
  these
  rats
  was
  not
  associated
with
  an
  increase
  in
  NMDA
  or
  AMPA
  receptor
  activation
(Weiss
  et
  al.,
  2007,
  2009,
  2012),
  suggesting
  that
  there
  may
be
 an
 increase
 in
 the
 activity
 of
 non-glutamatergic
 neurons.
Alternatively,
  the
  autistic
  brain
  may
  require
  more
metabolic
 substrate
 to
 produce
 the
 same
 amount
 of
 energy.
This
  is
  supported
  by
  increasing
  evidence
  that
  the
  func-
tion
  of
  the
  mitochondrial
  electron
  transport
  chain
  (ETC)
  is
impaired
  in
  autism.
  Compared
  to
  controls,
  a
  reduction
  in
the
  expression
  of
  ETC
  genes
  (Anitha
  et
  al.,
  2012)
  and
  pro-
teins
  (Chauhan
  et
  al.,
  2011)
  was
  seen
  in
  the
  post-mortem
brain
  tissue
  of
  patients
  with
  autism.
  Thus,
  oxidative
  phos-
phorylation
  may
  not
  be
  as
  effective
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perhaps
  requiring
  more
  oxygen
  and/or
  glucose
  to
  pro-
duce
  the
  same
  amount
  of
  ATP.
  Since
  the
  amount
  of
  energy
needed
  to
  restore
  ionic
  concentrations
  after
  neuronal
signalling
 is
 ﬁxed
 by
 the
 amount
 of
 sodium
 ion
 entry
 occur-
ring
 (Attwell
 and
 Laughlin,
 2001),
 this
 would
 imply
 a
 larger
oxygen
  requirement
  to
  support
  the
  same
  level
  of
  neuronal
activity.
  If
  this
  excess
  oxygen
  were
  obtained
  by
  increased
oxygen
  extraction
  from
  the
  blood,
  then
  this
  would
  lead
  to
a
  smaller
  BOLD
  response.
  However,
  in
  the
  mouse
  model
of
  autism,
  oxygen
  extraction
  is
  unchanged
  while
  cerebral
blood
  ﬂow
  is
  increased
  (Weiss
  et
  al.,
  2007,
  2008,
  2012),
suggesting
  that
  the
  excess
  oxygen
  is
  obtained
  by
  increased
vascular
  supply.
  This
  would
  lead
  to
  a
  larger
  BOLD
  response
to
  the
  same
  amount
  of
  neuronal
  activity
  in
  people
  with
autism.
7.
  Medication-related
  effects
  on
  neurovascular
coupling
The
  medication
  used
  to
  treat
  autism
  may
  also
  affect
the
  relationship
  between
  neuronal
  activity
  and
  the
  BOLD
response.
  For
  example,
  serotonin
  reuptake
  inhibitors
(SSRIs),
  a
  medication
  commonly
  used
  by
  autistic
  patients,
increase
  extracellular
  serotonin
  levels
  in
  the
  brain.
  They
may,
  therefore,
  increase
  the
  tone
  of
  vessels
  –
  perhaps
beyond
  normal
  levels
  –
  and
  thus
  alter
  the
  blood
  ﬂow
response
  evoked
  by
  neuronal
  activity
  (see
  above).
  A
  recent
study
  by
  Feczko
  et
  al.
  (2012)
  addressed
  this
  question,
  ﬁnd-
ing
  no
  signiﬁcant
  difference
  in
  the
  BOLD
  response
  to
  a
visuomotor
  task
  presented
  to
  non-medicated
  participants
and
  those
  taking
  SSRIs,
  in
  the
  brain
  areas
  they
  examined.
However,
  this
  does
  not
  rule
  out
  SSRI-induced
  neurovascu-
lar
  coupling
  changes
  in
  the
  brain
  circuits
  that
  underpin
  the
social
  behaviours
  more
  closely
  associated
  with
  the
  autistic
phenotype.
8.
  Potential
  impact
  of
  neurovascular
  coupling
changes
  in
  autism
  on
  fMRI
  studies
Having
  highlighted
  some
  of
  the
  neurophysiological
  dif-
ferences
  found
  in
  autism
  that
  may
  alter
  the
  relationship
between
  neuronal
  activity
  and
  the
  BOLD
  response
  in
  this
condition,
  we
  will
  now
  consider
  some
  fMRI
  studies
  in
which
  the
  results
  may
  be
  affected
  by
  these
  differences.
Goldberg
  et
  al.
  (2011)
  asked
  children
  with
  or
  without
high
  functioning
  autism
  spectrum
  disorder
  (ASD)
  to
  carry
out
  an
  error
  monitoring
  task.
  After
  a
  trial
  in
  which
  an
  error
was
  made,
  the
  BOLD
  signal
  in
  the
  anterior
  medial
  pre-
frontal
  cortex
  and
  the
  superior
  temporal
  gyrus
  was
  found
to
  increase
  in
  ASD
  participants
  compared
  to
  control
  partic-
ipants.
  This
  increase
  in
  the
  BOLD
  signal
  was
  interpreted
as
  increased
  neuronal
  activity
  in
  these
  regions.
  Because
the
  behavioural
  performance
  on
  the
  task
  was
  the
  same
for
  both
  groups,
  the
  assumed
  increase
  in
  neuronal
  activ-
ity
  was
  suggested
  to
  indicate
  a
  “greater
  attention
  towards
the
 internally-driven
 emotional
 state
 associated
 with
 mak-
ing
  an
  error”
  in
  children
  with
  ASD.
  But
  the
  authors
  did
not
  take
  any
  steps
  to
  rule
  out
  the
  possibility
  that
  the
difference
  between
  these
  groups
  may
  be
  neurovascular
in
  nature,
  and
  nothing
  to
  do
  with
  neuronal
  activity.
  For
instance,
  the
  increased
  nitric
  oxide
  level
  found
  in
  children
with
  autism
  (Zoro˘ glu
  et
  al.,
  2003)
  could
  lead
  to
  a
  larger
vascular
 response
 to
 activation
 of
 the
 same
 number
 of
 neu-
rons
  (see
  above).
  This
  would
  cause
  the
  BOLD
  response
  to
appear
 larger
 in
 children
 with
 autism,
 despite
 no
 difference
in
  neuronal
  activity.
Watanabe
  et
  al.
  (2012)
  found
  that
  the
  BOLD
  response
  to
a
  social
  judgement
  task
  was
  decreased
  in
  participants
  with
ASD
  compared
  to
  control
  participants.
  The
  degree
  of
  BOLD
signal
  reduction
  in
  the
  two
  regions
  most
  active
  in
  control
participants
  during
  this
  task
  (the
  anterior
  cingulate
  cor-
tex/ventromedial
  prefrontal
  cortex
  and
  the
  dorsal
  medial
prefrontal
  cortex)
  predicted
  the
  severity
  of
  communica-
tion
  deﬁcit
  in
  the
  ASD
  group.
  This
  result
  might
  suggest
  that
some
  physiological
  abnormality
  in
  these
  regions
  is
  associ-
ated
 with
 the
 behavioural
 abnormality
 in
 social
 judgement.
However,
  the
  idea
  that
  the
  physiological
  abnormality
  is
reduced
  neuronal
  activity
  can
  only
  be
  an
  assumption
  until
other
 possibilities
 are
 ruled
 out.
 For
 example,
 the
 decreased
serotonin
  levels
  seen
  in
  autistic
  patients
  (Chugani
  et
  al.,
1999a)
  may
  restrict
  the
  amplitude
  of
  the
  vascular
  and
  thus
the
  BOLD
  response
  (see
  above).
  The
  authors
  point
  out
  that
the
  reduction
  in
  the
  BOLD
  response
  in
  autistic
  partici-
pants
  is
  not
  global,
  as
  task-evoked
  activity
  in
  one
  area,
  the
amygdala,
  was
  found
  to
  increase.
  However,
  neurovascu-
lar
  coupling
  mechanisms
  can
  be
  pathway-speciﬁc
  (Enager
et
  al.,
  2009)
  and,
  therefore,
  task-speciﬁc.
  It
  is
  thus
  possible
that
  changes
  in
  neurovascular
  coupling
  are
  responsible
  for
either
 the
 decreased
 or
 increased
 BOLD
 responses
 found
 by
Watanabe
  et
  al.
  (2012).
Pfeifer
  et
  al.
  (2012)
  compared
  the
  BOLD
  signal
  when
participants
  were
  asked
  to
  make
  an
  appraisal
  of
  them-
selves
  or
  of
  others.
  In
  typically
  developing
  children
  and
adolescents,
 two
 main
 brain
 regions
 –
 the
 medial
 prefrontal
cortex
  (mPFC)
  and
  the
  middle
  cingulate
  cortex
  (MCC)
  –
showed
  an
  increased
  BOLD
  response
  during
  self-appraisal
compared
  to
  appraisal
  of
  others.
  Age-matched
  participants
with
  ASD
  lacked
  any
  task-related
  pattern
  in
  the
  mPFC,
  and
showed
  the
  opposite
  pattern
  in
  the
  MCC
  (increased
  BOLD
signal
  when
  appraising
  others
  compared
  to
  self).
  However,
with
 increasing
 age
 in
 the
 ASD
 group,
 the
 BOLD
 signal
 in
 the
mPFC
  associated
  with
  the
  differentiation
  of
  the
  self
  from
others
  was
  found
  to
  increase.
  This
  trend
  suggests
  that
  this
brain
 region
 is
 increasingly
 relied
 upon
 as
 the
 social
 impor-
tance
  of
  the
  self-other
  distinction
  is
  learned.
  However,
  the
interpretation
  of
  age-related
  BOLD
  changes
  comes
  with
  its
own
  set
  of
  issues,
  as
  the
  neurovasculature
  matures
  (Harris
et
  al.,
  2011),
  perhaps
  differently
  in
  autistic
  and
  typically
developing
  populations.
9.
  Experimentally
  excluding
  neurovascular
coupling
  differences
Since
  most
  researchers
  are
  interested
  in
  the
  neuronal
changes
  associated
  with
  autism,
  most
  changes
  in
  fMRI
response
  are
  simply
  assumed
  to
  be
  due
  to
  altered
  neuronal
processing
  rather
  than
  altered
  neurovascular
  coupling
  or
oxygen
  use.
  None
  of
  the
  studies
  above
  considered
  neu-
rovascular
  abnormalities
  in
  autism,
  which,
  if
  present
  could
directly
  affect
  the
  BOLD
  signal
  even
  in
  the
  absence
  of
changes
  in
  neuronal
  activity.
  The
  mislabelling
  of
  neu-
rovascular
  changes
  as
  neuronal
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be
  misleading.
  The
  best
  way
  to
  avoid
  this
  is
  with
  an
experimental
  design
  that
  can
  distinguish
  a
  neurovascular
coupling
  (or
  oxygen
  use)
  change
  from
  a
  neuronal
  activity
change.
  A
  few
  labs
  have
  begun
  to
  design
  experiments
  with
this
  goal
  in
  mind.
Feczko
  et
  al.
  (2012)
  asked
  children
  with
  and
  without
ASD
  to
  press
  a
  button
  at
  the
  onset
  and
  offset
  of
  a
  visually
presented
  ﬂickering
  chequerboard,
  and
  compared
  BOLD
responses
  in
  the
  two
  groups
  during
  this
  task
  in
  19
  differ-
ent
  brain
  regions.
  The
  same
  paradigm
  has
  previously
  been
employed
  to
  compare
  BOLD
  responses
  across
  age
  groups
(Kang
  et
  al.,
  2003).
  This
  approach
  assumes
  that
  the
  neu-
ronal
  activity
  mediating
  a
  simple,
  low-level
  task
  is
  not
affected
  by
  autism
  (or
  age).
  This
  assumption
  may
  not
  be
valid,
  since
  altered
  visual
  processing
  has
  been
  reported
  in
the
  retina
  and
  striate
  cortex
  in
  autism
  (Ritvo
  et
  al.,
  1988;
Simmons
  et
  al.,
  2009;
  Neumann
  et
  al.,
  2011;
  but
  see
  Koh
et
  al.,
  2010).
  But
  if
  it
  is
  a
  correct
  assumption,
  then
  identi-
cal
  BOLD
  responses
  in
  the
  two
  groups
  would
  presumably
imply
  that
  neurovascular
  coupling
  is
  the
  same
  in
  the
  two
groups.
Since
  Feczko
  et
  al.
  found
  no
  signiﬁcant
  difference
  in
the
  visual
  task-evoked
  BOLD
  response
  between
  ASD
  and
control
  children,
  they
  argued
  that
  neurovascular
  coupling
in
  the
  two
  groups
  must
  be
  the
  same,
  ideally
  throughout
the
  brain.
  This
  is
  the
  most
  parsimonious
  argument,
  but
the
  authors
  do
  acknowledge
  the
  small
  possibility
  that
  a
confounding
  difference
  in
  neurovascular
  coupling
  that
  has
equal
 and
 opposite
 effects
 to
 a
 difference
 in
 neuronal
 activ-
ity
 between
 the
 groups
 could
 lead
 to
 the
 same
 overall
 BOLD
signal.
  For
  example,
  a
  smaller
  amount
  of
  neuronal
  activity
in
  autism
  may
  be
  compensated
  for
  by
  a
  stronger
  neurovas-
cular
 signalling
 pathway,
 or
 vice
 versa.
 In
 this
 case,
 a
 similar
blood
  ﬂow
  response
  would
  be
  produced
  in
  the
  different
groups
  by
  differing
  levels
  of
  neuronal
  activity.
Even
  if
  one
  accepts
  the
  argument
  that
  a
  similar
  BOLD
response
  for
  a
  low
  level
  visual
  task
  implies
  similar
  neu-
rovascular
  coupling,
  as
  noted
  by
  the
  authors,
  it
  can
  only
  be
made
  for
  this
  particular
  visual
  task
  and
  need
  not
  generalise
to
  other
  tasks.
  As
  mentioned
  above,
  this
  is
  because
  differ-
ent
 tasks
 activate
 different
 brain
 regions,
 different
 neuronal
pathways
  and
  different
  neurotransmitter
  systems,
  which
vary
  in
  their
  neurovascular
  coupling
  mechanisms
  (Sloan
et
  al.,
  2010;
  Devonshire
  et
  al.,
  2012).
  Indeed,
  even
  within
the
  same
  brain
  region,
  neuronal
  activity
  evoked
  by
  differ-
ent
  inputs
  can
  generate
  different
  BOLD
  responses
  (Enager
et
  al.,
  2009).
Such
  input-
  or
  task-speciﬁc
  neurovascular
  coupling
makes
  it
  difﬁcult
  for
  results
  based
  on
  one
  task
  alone
  to
be
  extrapolated
  usefully
  to
  general
  claims
  about
  neurovas-
cular
  coupling
  between
  groups
  –
  it
  is
  always
  a
  possibility
that
  the
  chosen
  task
  happens
  to
  be
  one
  in
  which
  neu-
ronal
 responses
 and
 neurovascular
 coupling
 are
 not
 altered
between
  groups,
  while
  for
  tasks
  employing
  different
  brain
regions
  and
  pathways
  there
  may
  indeed
  be
  differences
  of
neurovascular
  coupling
  between
  the
  groups.
  For
  example,
in
  Feczko
  et
  al.’s
  case,
  it
  is
  possible
  that
  low
  level
  visual
areas
  do
  not
  have
  their
  neurovascular
  coupling
  altered
by
  the
  neuronal
  changes
  associated
  with
  autism,
  while
brain
  areas
  dealing
  with
  social
  interactions
  do
  have
  their
neurovascular
  coupling
  altered.
  Nevertheless,
  this
  study
represents
 the
 ﬁrst
 attempt
 to
 experimentally
 rule
 out
 neu-
rovascular
 coupling
 confounds
 in
 the
 interpretation
 of
 fMRI
data,
  and
  paves
  the
  way
  for
  paradigms
  which
  address
  this
issue
  directly.
Dinstein
  et
  al.
  (2012)
  used
  a
  different
  approach
to
  exclude
  the
  possibility
  that
  an
  increase
  in
  the
variability
  of
  neurovascular
  coupling
  in
  autism
  might
underpin
  the
  greater
  fMRI
  response
  variability
  that
  they
observed.
  Speciﬁcally,
  they
  found
  that,
  although
  mean
evoked
  responses
  to
  several
  stimuli
  (visual,
  auditory,
  and
somatosensory)
  did
  not
  differ
  between
  participants
  with
and
  without
  autism,
  there
  was
  a
  signiﬁcant
  increase
  in
trial-by-trial
  variability
  in
  participants
  with
  autism.
  They
compared
  these
  task-evoked
  responses
  in
  visual,
  auditory
or
 somatosensory
 regions
 (“local
 evoked
 activity”)
 with
 the
fMRI
  ﬂuctuations
  that
  were
  common
  to
  the
  entire
  cortex
  in
the
 absence
 of
 stimulus-evoked
 responses
 (“global
 ongoing
activity”),
  which
  did
  not
  show
  increased
  variability
  in
  par-
ticipants
  with
  autism.
  Because
  the
  authors
  started
  with
  the
assumption
 that
 a
 change
 in
 neurovascular
 coupling
 would
affect
  “evoked
  responses
  and
  ongoing
  activity
  in
  a
  similar
manner”,
 they
 argued
 that
 neurovascular
 coupling
 changes
could
  therefore
  not
  be
  the
  source
  of
  the
  increased
  variabil-
ity
  in
  the
  local
  task-evoked
  BOLD
  signals.
  The
  conclusion
followed
  that
  task-related
  neuronal
  activity
  is
  abnormally
unreliable
  in
  autism.
This
  line
  of
  reasoning
  on
  its
  own
  is
  weak,
  because
  there
is
  no
  reason
  why
  a
  neurovascular
  coupling
  change
  could
not
  selectively
  alter
  task-evoked
  signalling
  to
  the
  vascul-
ature
  without
  affecting
  resting
  state
  blood
  ﬂow.
  This
  is
obvious
  when
  one
  considers
  that
  the
  majority
  of
  neu-
rovascular
  coupling
  changes
  are
  likely
  to
  occur
  at
  points
along
  the
  pathway
  from
  synaptic
  transmission
  to
  vessel
dilation/constriction,
  and
  may
  therefore
  only
  be
  revealed
during
  task-evoked
  synaptic
  activity.
Nevertheless,
 Dinstein
 et
 al.’s
 conclusions
 are
 supported
by
  EEG
  data
  showing
  that
  visual
  task-evoked
  response
variability
  is
  signiﬁcantly
  greater
  in
  participants
  with
  ASD
(Milne,
  2011).
  The
  combination
  of
  fMRI
  with
  a
  direct
  mea-
sure
  of
  neuronal
  activity,
  such
  as
  EEG,
  is
  one
  of
  the
  most
hopeful
  approaches
  for
  experimentally
  dissecting
  out
  the
relative
  contributions
  of
  altered
  neuronal
  activity
  and
  neu-
rovascular
  coupling
  to
  differences
  in
  the
  BOLD
  signal.
For
  instance,
  an
  increased
  BOLD
  response
  echoed
  by
  an
increased
 EEG
 response
 to
 the
 same
 task
 is
 a
 very
 good
 indi-
cation
  that
  the
  BOLD
  increase
  reﬂects
  increased
  neuronal
activity.
  The
  fMRI
  data
  can
  then
  be
  used
  to
  gain
  a
  clearer
spatial
  picture
  of
  the
  change.
  If,
  however,
  BOLD
  and
  EEG
data
  contradict
  one
  another,
  this
  would
  indicate
  that
  other
factors
  –
  perhaps
  a
  change
  in
  neurovascular
  coupling
  or
energy
 use
 –
 are
 contributing
 to
 the
 BOLD
 signal
 difference.
In
  this
  way,
  performing
  EEG
  alongside
  fMRI
  can
  guide
  the
identiﬁcation
  of
  the
  neuronal
  differences
  between
  groups.
10.
  Conclusion
Autism
  is
  a
  brain
  disorder,
  with
  its
  diverse
  behavioural
phenotypes
  rooted
  in
  abnormalities
  of
  neuronal
  circuitry
and
  function,
  and
  we
  do
  not
  wish
  to
  suggest
  that
  fMRI
cannot
  reveal
  these
  neuronal
  differences.
  The
  aim
  of
  this
review
  is
  to
  dispel
  the
  idea
  that
  neurovascular
  coupling78 C.
  Reynell,
  J.J.
  Harris
  /
  Developmental
  Cognitive
  Neuroscience
  6 (2013) 72–
  79
can
  be
  lumped
  in
  with
  easily
  corrected
  for
  non-neuronal
confounds
  such
  as
  head
  motion
  or
  breathing
  artefacts.
  On
the
 contrary,
 neurovascular
 coupling
 changes
 can
 have
 pro-
found,
  complex
  and
  region-
  and
  task-speciﬁc
  effects
  on
cerebral
  blood
  ﬂow
  and
  therefore
  the
  BOLD
  signal.
Autism
  is
  associated
  with
  many
  neurophysiological
changes,
  and
  there
  are
  just
  as
  many
  reasons
  why
  an
  abnor-
mal
  relationship
  between
  neuronal
  activity
  and
  the
  BOLD
signal
  might
  therefore
  be
  expected.
  Being
  aware
  of
  these
potential
  neurovascular
  coupling
  and
  energy
  use
  differ-
ences
  will
  be
  critical
  to
  the
  ﬁeld’s
  ability
  to
  dissect
  out
the
  neuronal
  changes
  that
  underpin
  behavioural
  differ-
ences.
  Eventually,
  detailed
  knowledge
  of
  the
  physiology
of
  the
  BOLD
  signal
  (Attwell
  and
  Iadecola,
  2002)
  will
  allow
more
  conﬁdent
  interpretation
  of
  BOLD
  response
  differ-
ences
  between
  participants.
  The
  most
  promising
  way
  to
achieve
 this
 is
 by
 using
 a
 combination
 of
 imaging
 and
 physi-
ological
 research
 in
 animals
 (Devonshire
 et
 al.,
 2012;
 Schulz
et
 al.,
 2012).
 Meanwhile,
 an
 experimental
 approach
 –
 based
around
  carefully
  chosen
  control
  tasks
  or
  a
  combination
  of
fMRI
  and
  EEG
  (or,
  indeed,
  any
  method
  that
  reports
  the
electrical
  activity
  of
  neurons,
  such
  as
  MEG)
  –
  is
  the
  best
strategy
  to
  distinguish
  the
  contributions
  of
  neurovascular
coupling
  and
  of
  neuronal
  activity
  to
  differences
  in
  BOLD
signals
  between
  groups.
Conﬂict
  of
  interest
The
  authors
  declare
  no
  conﬂict
  of
  interest.
Acknowledgements
Supported
  by
  the
  MRC,
  Wellcome
  Trust,
  Fondation
Leducq
  and
  ERC.
  We
  thank
  David
  Attwell,
  Renaud
  Jolivet
and
  Anusha
  Mishra
  for
  comments
  on
  the
  manuscript.
References
Anitha,
  A.,
  Nakamura,
  K.,
  Thanseem,
  I.,
  Matsuzaki,
  H.,
  Miyachi,
  T.,
  Tsujii,
M.,
  Iwata,
  Y.,
  Suzuki,
  K.,
  Sugiyama,
  T.,
  Nori,
  N.,
  2012.
  Downregulation
of
  the
  expression
  of
  mitochondrial
  electron
  transport
  complex
  genes
in
  autism
  brains.
  Brain
  Pathol.
  [Epub
  ahead
  of
  print].
Attwell,
  D.,
  Laughlin,
  S.B.,
  2001.
  An
  energy
  budget
  for
  signaling
  in
  the
  grey
matter
  of
  the
  brain.
  J.
  Cereb.
  Blood
  Flow
  Metab.
  21,
  1113–1145.
Attwell,
 D.,
 Iadecola,
 C.,
 2002.
 The
 neuronal
 basis
 of
 functional
 brain
 imag-
ing
  signals.
  Trends
  Neurosci.
  25,
  621–625.
Attwell,
  D.,
  Buchan,
  A.M.,
  Charpak,
  S.,
  Lauritzen,
  M.,
  MacVicar,
  B.A.,
  New-
man,
  E.A.,
  2010.
  Glial
  and
  neuronal
  control
  of
  brain
  blood
  ﬂow.
  Nature
468,
  232–243.
Belger,
 A.,
 Carpenter,
 K.L.,
 Yucel,
 G.H.,
 Cleary,
 K.M.,
 Donkers,
 F.C.,
 2011.
 The
neuronal
  circuitry
  of
  autism.
  Neurotox.
  Res.
  20,
  201–214.
Blanco,
  V.M.,
  Stern,
  J.E.,
  Filosa,
  J.A.,
  2008.
  Tone-dependent
  vascular
responses
  to
  astrocyte-derived
  signals.
  Am.
  J.
  Physiol.
  Heart
  Circ.
Physiol.
  294,
  H2855–H2863.
Chauhan,
  A.,
  Gu,
  F.,
  Essa,
  M.M.,
  Wegiel,
  J.,
  Kaur,
  K.,
  Brown,
  W.T.,
  Chauhan,
V.,
  2011.
  Brain
  region-speciﬁc
  deﬁcit
  in
  mitochondrial
  electron
  trans-
port
  chain
  complexes
  in
  children
  with
  autism.
  J.
  Neurochem.
  117,
209–220.
Chugani,
  D.C.,
  Muzik,
  O.,
  Behen,
  M.,
  Rothermel,
  R.,
  Janisse,
  J.J.,
  Lee,
  J.,
Chugani,
  H.T.,
  1999a.
  Developmental
  changes
  in
  brain
  serotonin
  syn-
thesis
  capacity
  in
  autistic
  and
  nonautistic
  children.
  Neurology
  45,
287–295.
Chugani,
 D.C.,
 Bhavani,
 S.S.,
 Behen,
 M.,
 Lee,
 M.,
 Moore,
 G.J.,
 1999b.
 Evidence
of
  altered
  energy
  metabolism
  in
  autistic
  children.
  Prog.
  Neuropsy-
chopharmacol.
  Biol.
  Psychiatry
  23,
  635–641.
Cohen,
  Z.,
  Bonvento,
  G.,
  Lacombe,
  P.,
  Hamel,
  E.,
  1997.
  Serotonin
  in
  the
regulation
  of
  brain
  microcirculation.
  Prog.
  Neurobiol.
  50,
  335–362.
DeVolder,
  A.G.,
  Bol,
  A.,
  Micel,
  C.,
  Cogneau,
  M.,
  Gofﬁnet,
  A.M.,
  1987.
  Brain
glucose
  metabolism
  in
  children
  with
  the
  autistic
  syndrome:
  positron
tomography
  analysis.
  Brain
  Dev.
  9
  (6),
  581–587.
Devonshire,
  I.M.,
  Papadakis,
  N.G.,
  Port,
  M.,
  Berwick,
  J.,
  Kennerley,
  A.J.,
Mayhew,
  J.E.W.,
  Overton,
  P.G.,
  2012.
  Neurovascular
  coupling
  is
  brain
region-dependent.
  Neuroimage
  59,
  1997–2006.
Dinstein,
  I.,
  Heeger,
  D.J.,
  Lorenzi,
  L.,
  Minshew,
  N.J.,
  Malach,
  R.,
  Behrmann,
M.,
  2012.
  Unreliable
  evoked
  responses
  in
  autism.
  Neuron
  75,
981–991.
Enager,
  P.,
  Piilgaard,
  H.,
  Offenhauser,
  N.,
  Kocharyan,
  A.,
  Fernandes,
P.,
  Hamel,
  E.,
  Lauritzen,
  M.,
  2009.
  Pathway-speciﬁc
  variations
in
  neurovascular
  and
  neurometabolic
  coupling
  in
  rat
  primary
somatosensory
  cortex.
  J.
  Cereb.
  Blood
  Flow
  Metab.
  29,
  976–986.
Fatemi,
  S.H.,
  Cuadra,
  A.E.,
  El-Fakahany,
  E.E.,
  Sidwell,
  R.W.,
  Thuras,
  P.D.,
2000.
  Prenatal
  viral
  infection
  causes
  alterations
  in
  nNOS
  expression
in
  developing
  mouse
  brains.
  Neuroreport
  11
  (7),
  1493–1496.
Fatemi,
  S.H.,
  Halt,
  A.R.,
  Stary,
  J.M.,
  Kanodia,
  R.,
  Schulz,
  S.C.,
  Realmuto,
G.R.,
  2002.
  Glutamic
  acid
  decarboxylase
  65
  and
  67
  kDa
  proteins
  are
reduced
 in
 autistic
 paretial
 and
 cerebellar
 cortices.
 Biol.
 Psychiatry
 52,
805–810.
Fatemi,
  S.H.,
  Reutiman,
  T.J.,
  Folsom,
  T.D.,
  Thuras,
  P.D.,
  2009.
  GABAA
  recep-
tor
  downregulation
  in
  brains
  of
  subjects
  with
  autism.
  J.
  Autism
  Dev.
Disord.
  39,
  223–230.
Fatemi,
  S.H.,
  Reutiman,
  T.J.,
  Folsom,
  T.D.,
  Rooney,
  R.J.,
  Patel,
  D.H.,
  Thuras,
P.D.,
  2010.
  mRNA
  and
  protein
  levels
  for
  GABA
  A4,
  5,
  1
  and
GABABR1
  receptors
  are
  altered
  in
  brains
  from
  subjects
  with
  autism.
  J.
Autism
  Dev.
  Disord.
  40,
  743–750.
Fatemi,
  S.H.,
  Folsom,
  T.D.,
  2011.
  Dysregulation
  of
  fragile
  X
  mental
  retarda-
tion
 protein
 and
 metabotropic
 glutamate
 receptor
 5
 in
 superior
 frontal
cortex
  of
  individuals
  with
  autism:
  a
  postmortem
  brain
  study.
  Mol.
Autism
  2,
  6.
Fatemi,
  S.H.,
  Folsom,
  T.D.,
  Kneeland,
  R.E.,
  Liesch,
  S.B.,
  2011.
  Metabotropic
glutamate
  receptor
  5
  upregulation
  in
  children
  with
  autism
  is
  asso-
ciated
  with
  underexpression
  of
  both
  Fragile
  X
  mental
  retardation
protein
  and
  GABAA
  receptor
  beta
  3
  in
  adults
  with
  autism.
  Anat.
  Rec.
294,
  1635–1645.
Feczko,
  E.,
  Miezin,
  F.M.,
  Constantino,
  J.N.,
  Schlagger,
  B.L.,
  Peterson,
  S.E.,
Pruett,
 J.R.,
 2012.
 The
 hemodynamic
 response
 in
 children
 with
 simplex
autism.
  Dev.
  Cogn.
  Neurosci.
  2,
  396–408.
Friston,
  K.,
  1995.
  Commentary
  and
  opinion:
  II,
  statistica
  parametric
  map-
ping:
  ontology
  and
  current
  issues.
  J.
  Cereb.
  Blood
  Flow
  Metab.
  15,
361–370.
Friston,
 K.,
 Ashburner,
 J.T.,
 Kiebel,
 S.J.,
 Nichols,
 T.E.,
 Penny,
 W.D.,
 2007.
 Sta-
tistical
  Parametric
  Mapping:
  The
  Analysis
  of
  Functional
  Brain
  Images.
Academic
  Press,
  London.
Goldberg,
  C.M.,
  Spinelli,
  S.,
  Joel,
  S.,
  Pekar,
  J.J.,
  Denckla,
  M.B.,
  Mostofsky,
S.H.,
  2011.
  Children
  with
  high
  functioning
  autism
  show
  increased
prefrontal
  and
  temporal
  cortex
  activity
  during
  error
  monitoring.
  Dev.
Cogn.
  Neurosci.
  1,
  47–56.
Hampson,
  D.R.,
  Gholizadeh,
  S.,
  Pacey,
  L.K.,
  2012.
  Pathways
  to
  drug
  devel-
opment
  for
  autism
  spectrum
  disorders.
  Clin.
  Pharmacol.
  Ther.
  91,
189–200.
Harris,
  J.J.,
  Reynell,
  C.,
  Attwell,
  D.,
  2011.
  The
  physiology
  of
  developmental
changes
  in
  BOLD
  functional
  imaging
  signals.
  Dev.
  Cogn.
  Neurosci.
  1,
199–216.
Herold,
  S.,
  Frackowiak,
  R.S.J.,
  Le
  Couteur,
  A.,
  Rutter,
  M.,
  Howlin,
  P.,
  1988.
Cerebral
  blood
  ﬂow
  and
  metabolism
  of
  oxygen
  and
  glucose
  in
  young
autistic
  adults.
  Psychol.
  Med.
  18,
  823–831.
Kang,
  H.C.,
  Burgund,
  E.D.,
  Lugar,
  H.M.,
  Peterson,
  S.E.,
  Schlagger,
  B.L.,
  2003.
Comparison
  of
  functional
  activation
  foci
  in
  children
  and
  adults
  using
a
  common
  stereotactic
  space.
  Neuroimage
  19,
  16–28.
Kaya,
 M.,
 Karasaliho˘ glu,
 S.,
 Ustün,
 F.,
 Gültekin,
 A.,
 Cermik,
 T.F.,
 Fazlio˘ glu,
 Y.,
Türe,
  M.,
  Yi˘ gitbas ¸
 i,
  O.N.,
  Berkarda,
  S.,
  2002.
  The
  relationship
  between
99mTc-HMPAO
  brain
  SPECT
  and
  the
  scores
  of
  real
  life
  rating
  scale
  in
autistic
  children.
  Brain
  Dev.
  24,
  77–81.
Kocharyn,
  A.,
  Fernandes,
  P.,
  Tong,
  X.K.,
  Vaucher,
  E.,
  Hamel,
  E.,
  2008.
  Spe-
ciﬁc
 cubtypes
 of
 cortical
 interneurons
 contribute
 to
 the
 neurovascular
coupling
  response
  to
  basal
  forebrain
  stimulation.
  J.
  Cereb.
  Blood
  Flow
Metab.
  28,
  221–231.
Koh,
  H.C.,
  Milne,
  E.,
  Dobkins,
  K.,
  2010.
  Spatial
  contrast
  sensitivity
  in
  ado-
lescents
  with
  autism
  spectrum
  disorders.
  J.
  Autism
  Dev.
  Disord.
  40,
978–987.
Logothetis,
  N.K.,
  Pauls,
  J.,
  Augath,
  M.,
  Trinath,
  T.,
  Oeltermann,
  A.,
  2001.
Neurophysiological
  investigation
  of
  the
  basis
  of
  the
  fMRI
  signal.
Nature
  412,
  150–157.
Logothetis,
  N.K.,
  Wandell,
  B.A.,
  2004.
  Interpreting
  the
  BOLD
  signal.
  Annu.
Rev.
  Physiol.
  66,
  735–769.
Magistretti,
  P.J.,
  Pellerin,
  L.,
  Rothman,
  D.L.,
  Shulman,
  R.G.,
  1999.
  Energy
  on
demand.
  Science
  283,
  496–497.C.
  Reynell,
  J.J.
  Harris
  /
  Developmental
  Cognitive
  Neuroscience
  6 (2013) 72–
  79 79
Makkonen,
  I.,
  Riikonen,
  R.,
  Kokki,
  H.,
  Airaksinen,
  M.M.,
  Kuikka,
  J.T.,
  2008.
Serotonin
  and
  dopamine
  transporter
  binding
  in
  children
  with
  autism
determined
  by
  SPECT.
  Dev.
  Med.
  Child
  Neurol.
  50,
  593–597.
Milne,
  E.,
  2011.
  Increased
  intra-participant
  variability
  in
  children
  with
autistic
  spectrum
  disorders:
  evidence
  from
  single-trial
  analysis
  of
evoked
  EEG.
  Front.
  Psychol.
  2,
  1–12.
Neumann,
  N.,
  Dubischar-Krivec,
  A.M.,
  Poustka,
  F.,
  Birbaumer,
  N.,
  Bölte,
  S.,
Braun,
  C.,
  2011.
  Electromagnetic
  evidence
  of
  altered
  visual
  processing
in
  autism.
  Neuropsychologia
  49,
  3011–3017.
Pfeifer,
  J.H.,
  Merchant,
  J.S.,
  Colich,
  N.L.,
  Hernandez,
  L.M.,
  Rudie,
  J.D.,
Dapretto,
  M.,
  2012.
  Neural
  and
  behavioural
  responses
  during
  self-
evaluative
 processes
 differ
 in
 youth
 with
 and
 without
 autism.
 J.
 Autism
Dev.
  Disord.
  [Epub
  ahead
  of
  print].
Ritvo,
  E.R.,
  Creel,
  D.,
  Realmuto,
  G.,
  Crandall,
  A.S.,
  Freeman,
  B.J.,
  Bateman,
J.B.,
  Barr,
  R.,
  Pingree,
  C.,
  Coleman,
  M.,
  Purple,
  R.,
  1988.
  Electroretino-
grams
 in
 autism:
 a
 pilot
 study
 of
 b-wave
 amplitudes.
 Am.
 J.
 Psychiatry.
145,
  229–232.
Rumsey,
  J.M.,
  Duara,
  R.,
  Grady,
  C.,
  Rapoport,
  J.L.,
  Margolin,
  R.A.,
  Rapoport,
S.I.,
  Cutler,
  N.R.,
  1985.
  Brain
  metabolism
  in
  autism,
  resting
  cerebral
glucose
  utilization
  rates
  as
  measured
  with
  positron
  emission
  tomo-
graphy.
  Arch.
  Gen.
  Psychiatry.
  42,
  448–455.
Schulz,
  K.,
  Sydekum,
  E.,
  Krueppel,
  R.,
  Engelbrecht,
  C.J.,
  Schlegel,
  F.,
Schroter,
  A.,
  Rudin,
  M.,
  Helmchen,
  F.,
  2012.
  Simultaneous
  BOLD
  fMRI
and
  ﬁber-optic
  calcium
  recording
  in
  rat
  neocortex.
  Nat.
  Methods
  9,
597–602.
Simmons,
  D.,
  Robertson,
  A.E.,
  McKay,
  L.S.,
  Toal,
  E.,
  McAleer,
  P.,
  Pollick,
  F.,
2009.
 Vision
 in
 autism
 spectrum
 disorders.
 Vision
 Res.
 49,
 2705–2739.
Sloan,
  H.L.,
  Austin,
  V.C.,
  Blamire,
  A.M.,
  Schnupp,
  J.W.,
  Lowe,
  A.S.,
  Allers,
K.A.,
  Matthews,
  P.M.,
  Sibson,
  N.R.,
  2010.
  Regional
  differences
  in
neurovascular
  coupling
  in
  rat
  brain
  as
  determined
  by
  fMRI
  and
  elec-
trophysiology.
  Neuroimage
  53,
  399–411.
Sun,
  W.,
  McConnell,
  E.,
  Pare,
  J.F.,
  Xu,
  Q.,
  Chen,
  M.,
  Peng,
  W.,
  Lovatt,
  D.,
  Han,
X.,
  Smith,
  Y.,
  Nedergaard,
  M.,
  2013.
  Glutamate-dependent
  neuroglial
calcium
  signaling
  differs
  between
  young
  and
  adult
  brain.
  Science
  339,
197–200.
Watanabe,
  T.,
  Yahata,
  N.,
  Abe,
  O.,
  Kuwabara,
  H.,
  Inoue,
  H.,
  Takano,
  Y.,
Iwashiro,
  N.,
  Natsubori,
  T.,
  Aoki,
  Y.,
  Takao,
  H.,
  Sasaki,
  H.,
  Gonoi,
  W.,
Murakami,
  M.,
  Katsura,
  M.,
  Kunimatsu,
  A.,
  Kawakubo,
  Y.,
  Matsuzaki,
H.,
 Tsuchiya,
 K.J.,
 Kato,
 N.,
 Kano,
 Y.,
 Miyashita,
 Y.,
 Kasai,
 K.,
 Yamasue,
 H.,
2012.
  Diminished
  prefrontal
  activity
  behind
  autistic
  social
  judgments
of
  incongruent
  information.
  PLoS
  One
  7,
  e39561.
Weiss,
  H.R.,
  Liu,
  X.,
  Zhang,
  Q.,
  Chi,
  O.Z.,
  2007.
  Increased
  cerebral
  oxygen
consumption
  in
  Eker
  rats
  and
  effects
  of
  N-methyl-D-aspartate
  block-
ade:
  implications
  for
  autism.
  J.
  Neurosci.
  Res.
  85,
  2512–2517.
Weiss,
  H.R.,
  Liu,
  X.,
  Chi,
  O.Z.,
  2008.
  Cerebral
  O(2)
  consumption
  in
  young
Eker
 rats,
 effects
 of
 GABA
 blockade:
 implications
 for
 autism.
 Int.
 J.
 Dev.
Neurosci.
  26,
  517–521.
Weiss,
  H.R.,
  Liu,
  X.,
  Hunter,
  C.,
  Chi,
  O.Z.,
  2009.
  Effects
  of
  alpha-amino-
3-hydroxy-5-methyl-4-isoxazole
  propionic
  acid
  (AMPA)
  receptor
blockade
  on
  increased
  cerebral
  O(2)
  consumption
  in
  Eker
  rats.
  Brain
Res.
  1294,
  138–143.
Weiss,
  H.R.,
  Liu,
  X.,
  Grewal,
  P.,
  Chi,
  O.Z.,
  2012.
  Reduced
  effect
  of
  stimula-
tion
  of
  AMPA
  receptors
  on
  cerebral
  O2 consumption
  in
  a
  rat
  model
  of
autism.
  Neuropharmacology
  63,
  837–841.
Zoro˘ glu,
  S.S.,
  Yurekli,
  M.,
  Meram,
  I.,
  So˘ gut,
  S.,
  Tutkan,
  H.,
  Yetkin,
  O.,
  Sivasli,
E.,
  Savas ¸
 ,
  H.A.,
  Yanik,
  M.,
  Herken,
  H.,
  Akyol,
  O.,
  2003.
  Pathophysiolo-
gical
  role
  of
  nitric
  oxide
  and
  adrenomedullin
  in
  autism.
  Cell
  Biochem.
Funct.
  23,
  55–60.